What Precision Ocular Network does

Precision Ocular Network (PON) is a 501c3 nonprofit eye banking organization formed through the 2025 merger of Advancing Sight Network and Miracles In Sight, headquartered in Birmingham, Alabama. PON recovers, processes, and distributes human ocular tissue for corneal and other ophthalmic transplant surgeries, supplying surgeons, hospitals, and surgical centers across a multi-state US footprint spanning Alabama, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas. The organization also holds certifications in seven international jurisdictions (Canada, Egypt, Germany, Greece, Israel, Mexico, Netherlands), enabling cross-border tissue export.

PON's core products fall into two streams. The first is surgical tissue: corneas and other ocular tissues supplied to ophthalmic surgeons for transplantation, recovered from deceased donors through hospital and organ procurement organization partnerships. The second is research tissue, anchored by the newly launched Precision Ocular Biobank, which supplies human ocular tissues, cells, and slides to pharmaceutical, biotech, and academic research clients, with a stated strategic focus on cellular therapeutics and clinical trials support.

The business model combines transaction-based revenue from surgical tissue provision, third-party insurance reimbursement for corneal transplants, philanthropic donations consistent with 501c3 status, and fee-for-service revenue from research tissue supply. PON is governed under a co-CEO leadership structure (Alan Blake and Ingrid Schunder) reflecting the integration of the two legacy organizations, and operates with the regulatory accreditations (EBAA, FDA tissue establishment licensure, international certifications) required for ocular tissue banking.

Name

Precision Ocular Network

Legal name

Precision Ocular Network

Website

https://precisionocular.org

Company type

Private

Founded year

2026

Operating status

Operating

Short description

Precision Ocular Network is a 501c3 nonprofit eye bank that recovers, processes, and distributes human ocular tissue for transplant surgeons and supplies research-grade ocular tissues, cells, and slides through its Precision Ocular Biobank to pharmaceutical, biotech, and academic clients across the US Southeast and seven international jurisdictions.

Ownership category

akta.pro rank

Product category

Eye Banking and Ocular Tissue Services

NAICS

Ophthalmic Goods Merchant Wholesalers (423460)

SIC

Ophthalmic Goods (3851)

akta.pro primary industry

Oculoplastics & Orbital Surgery (HLAKAKAI)

akta.pro secondary industries

Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Retina & Vitreous Specialists (HLAKAKAE)

Keywords

• Eye banking services
• Ocular tissue recovery
• Corneal transplantation supply
• Ocular research tissue
• Sight restoration services

Headquarters

HQ city

Birmingham

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Ocular Tissue Services: Recovery, processing, and distribution of ocular tissue to surgical providers for transplantation procedures. Revenue derived from service fees associated with tissue procurement and preparation.
2. Insurance Reimbursement: Most corneal transplant expenses are covered through patient insurance. The organization operates within healthcare billing systems for covered procedures.
3. Philanthropic Donations: Financial gifts from donors supporting eye banking services, research initiatives, community outreach, and donor family aftercare programs. Includes stock gifts, planned giving, and major gifts.
4. Research Tissue Provision: Supply of ocular tissue to researchers through the Precision Ocular Biobank for research purposes including cellular therapeutics and clinical trials.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Precision Ocular Network is a nonprofit eye banking organization that recovers, processes, evaluates, and distributes human ocular tissue to surgical providers (ophthalmologists and corneal transplant surgeons) for transplantation and sight restoration procedures. The organization also supplies ocular tissue to pharmaceutical, biotech, and academic researchers through its Precision Ocular Biobank for cellular therapeutics, retinal vision loss research, and clinical trial applications.

Product overview

Precision Ocular Network is a nonprofit eye banking organization formed through the merger of Advancing Sight Network and Miracles In Sight. The organization offers a unified portfolio of eye banking services (ocular tissue recovery and distribution), a dedicated Precision Ocular Biobank for research, and an eye tissue donation program. Services are delivered through a network of regional offices across the United States (Alabama, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, Texas) and international partnerships, with a focus on compassionate care, surgical support, and advancing sight restoration science.

Differentiator

Problem solved

Functional benefit

Products and services

• Eye Banking Services Recovery, evaluation, processing, storage, and distribution of human ocular tissue with tight recovery timelines for surgical providers performing corneal transplantation and sight restoration procedures.
• Precision Ocular Biobank Research-oriented biobank supplying ocular tissue to pharmaceutical, biotech, and academic researchers for studies on blinding diseases, cellular therapeutics, retinal vision loss, and clinical trials.
• Eye Tissue Donation Program Facilitates eye tissue donation by registering donors across Alabama, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas and working with donor families to recover ocular tissue with empathy and efficiency.
• Research Services Collaborative research initiatives focused on cellular therapeutics and clinical trials, with the goal of finding effective treatments or cures for blinding diseases and retinal vision loss.

Quantifiable outcome

• 253 million people globally affected by blindness or moderate to severe visual impairment, with 90% preventable or treatable

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core.

• Advancing Sight NetworkcoreStrategic or Co-development PartnerLegacy organization merged into Precision Ocular Network. Advancing Sight Network contributed its eye banking expertise, surgeon relationships, and regional operations in Alabama and surrounding states to form the combined organization.
• Miracles In SightcoreStrategic or Co-development PartnerLegacy organization merged into Precision Ocular Network. Miracles In Sight contributed its eye banking operations, including facilities in North Carolina and Texas, and its established network of surgeon partners to the combined entity.
• ASN SurgeonscoreStrategic or Co-development PartnerNetwork of surgical providers affiliated with the legacy Advancing Sight Network who rely on Precision Ocular Network for quality ocular tissue for transplantation procedures.
• MIS SurgeonscoreStrategic or Co-development PartnerNetwork of surgical providers affiliated with the legacy Miracles In Sight who depend on Precision Ocular Network for ocular tissue supply for cornea transplants and related procedures.
• Precision Ocular BiobankcoreStrategic or Co-development PartnerResearch-oriented biobank providing ocular tissue for researchers studying blinding diseases, cellular therapeutics, and clinical trials. Operated as a key component of the organization's research and innovation mission.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Ocular Network